within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07C_BacterialAndViralVaccinesCombined.J07CA03_DiphtheriaRubellaTetanus;

model DiphtheriaRubellaTetanus
  extends Pharmacolibrary.Drugs.ATC.J.J07CA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J07CA03</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>The diphtheria-rubella-tetanus (DRT) vaccine is a combined immunization used primarily to protect against three infectious diseases: diphtheria, caused by Corynebacterium diphtheriae; rubella, caused by rubella virus; and tetanus, caused by Clostridium tetani. This vaccine is widely used in routine childhood immunization schedules across the globe and is approved for use today to prevent these diseases.</p><h4>Pharmacokinetics</h4><p>There are no published pharmacokinetic (PK) models or quantitative PK parameters available for the diphtheria-rubella-tetanus vaccine in the literature. The vaccine consists of inactivated bacterial toxoids (diphtheria, tetanus) and live-attenuated virus (rubella) administered intramuscularly, and the pharmacokinetic evaluation is not typically performed for vaccines. The following parameters are not available and are left empty or default as appropriate.</p><h4>References</h4><ol><li><p>Lugo, RA, &amp; Kern, SE (2002). Clinical pharmacokinetics of morphine. <i>Journal of pain &amp; palliative care pharmacotherapy</i> 16(4) 5–18. DOI:<a href=&quot;https://doi.org/10.1080/j354v16n04_02&quot;>10.1080/j354v16n04_02</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14635822/&quot;>https://pubmed.ncbi.nlm.nih.gov/14635822</a></p></li><li><p>Wang, W, et al., &amp; Balthasar, JP (2008). Monoclonal antibody pharmacokinetics and pharmacodynamics. <i>Clinical pharmacology and therapeutics</i> 84(5) 548–558. DOI:<a href=&quot;https://doi.org/10.1038/clpt.2008.170&quot;>10.1038/clpt.2008.170</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18784655/&quot;>https://pubmed.ncbi.nlm.nih.gov/18784655</a></p></li><li><p>Groborz, O, et al., &amp; Hrubý, M (2022). Pharmacokinetics of Intramuscularly Administered Thermoresponsive Polymers. <i>Advanced healthcare materials</i> 11(22) e2201344–None. DOI:<a href=&quot;https://doi.org/10.1002/adhm.202201344&quot;>10.1002/adhm.202201344</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36153823/&quot;>https://pubmed.ncbi.nlm.nih.gov/36153823</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end DiphtheriaRubellaTetanus;
